BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2024-00234 CTQJ230A12203 - A randomized double-blind, placebo-controlled, multi-center trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve s More ... clinical trial drugs phase 2 multicentric C Dr. med. Jonathan Michel Novartis Pharma Schweiz Universitätsspital Zürich, Zürich
Universitätsspital Basel, Basel
HUG, Geneve
EOC, Lugano
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Commission Cantonale d'éthique de la recherche Genève (CCER), Comitato etico cantonale Ticino 19.04.2024
2024-00233 A superiority randomized controlled study on the efficacy of radiofrequency for the treatment of women patients with overactive bladder syndrome clinical trial other clinical trials monocentric B PD Dr. med. Andrea Braga Dept. Obstetrics and Gynaecology, EOC - Beata Vergine Hospital Dept. Obstetrics and Gynaecology, EOC - Beata Vergine Hospital, Mendrisio
Comitato etico cantonale Ticino 26.08.2024
2024-00231 Ticin regIstry for caTheter-based treAtments iN patIents with acute pUlmonary eMbolism non clinical, involving persons monocentric A Prof Marco Valgimigli Cardiocentro Ticino Institute, EOC Cardiocentro Ticino Institute, EOC, Lugano, Lugano
Comitato etico cantonale Ticino 14.05.2024
2024-00230 MK-2870-019: A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC not Achieving pCR After Receiving Neoad More ... clinical trial drugs phase 3 multicentric C PD Dr. med. Michael Mark Merck Sharp & Dohme LLC Kantonsspital Graubünden, Chur
Spital Thurgau AG, Thurgau
HFR hôpital fribourgeois, Fribourg
Kantonale Ethikkommission Zürich Ethikkommission Ostschweiz (EKOS), Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 30.04.2024
2024-00229 Biomechanical Evaluation of Various Refixation Techniques Following Extended Trochanteric Osteotomy and Trochanteric Fractures in a Cadaver Model deceased persons monocentric Prof. Dr. med. Patrick Zingg Universitätsklinik Balgrist Universitätsklinik Balgrist, Zürich
Kantonale Ethikkommission Zürich 12.04.2024
2024-00228 TRINITY – Use of commercial human milk samples for in-vitro assays personal data/biological material monocentric Lucile Yart La Société La Société des Produits Nestlé, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 23.12.2024
2024-00225 Initial experience with Simultaneous Pancreas- and Kidney Transplantations from Donors after Circulatory Death in Switzerland and review of the current literature personal data/biological material monocentric Dr. med. Fabian Rössler Department of Surgery and Transplantation, University Hospital of Zürich University Hospital of Zürich, Zürich
Kantonale Ethikkommission Zürich 26.03.2024
2024-00224 One year results and comparison of two double mobility prostheses for trapeziometacarpal arthritis personal data/biological material monocentric Sebastian Hediger Kantonsspital Frauenfeld Kantonsspital Frauenfeld, Frauenfeld
Ethikkommission Ostschweiz (EKOS) 08.02.2024
2024-00223 Efficacy of Transversus Thoracic Muscle Plane Block in Patients undergoing Cardiac Surgery
A randomized controlled, double blind trial
clinical trial other clinical trials monocentric A PD Dr Sina Grape Hôpital du Valais Service d'Anesthésiologie, Centre Hospitalier du Valais Romand, Sion
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 30.04.2024
2024-00222 Malleostapedotomy: a 20-year updated review of surgical results personal data/biological material monocentric Prof. Dr. med. Thomas Linder HNO LUKS HNO LUKS, Luzern
Ethikkommission Nordwest- und Zentralschweiz EKNZ 27.02.2024
2024-00220 ADE (adverse drug event) Hospitalization – inadäquate Medikation bei geriatrisch hämatologisch-onkologischen Patientinnen und Patienten personal data/biological material monocentric Dr. med. Wiebke Rösler University Hospital Zurich University Hospital Zurich, Zurich
Kantonale Ethikkommission Zürich 25.06.2024
2024-00219 Clinical, radiological and patient related outcomes in Legg-Calvé-Perthès disease. A monocentric case series non clinical, involving persons monocentric A Dre Sophie Merkaert CHUV - DFME - Chirurgie Hôpital de l’enfance, Centre Hospitalier Universitaire Vaudois, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 13.05.2024 yes
2024-00218 Evaluation of the electrical and mechanical properties of the glioblastoma microenvironment and the tumor interactions with existing neural circuits personal data/biological material monocentric Prof. Dr. Dr. G. Hutter NCH Basel NCH Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 14.02.2024
2024-00217 Brachytherapy versus surgery in localized squamous cell carcinoma of the lip: a propensity-matched survival analysis non clinical, involving persons monocentric A PD Dr. med. Olgun Elicin Inselspital Universitätsklinik für Radio-Onkologie, Bern
Kantonale Ethikkommission Bern 03.07.2024
2024-00216 Processing Spoken Language and Cognition in Chronic Subjective Tinnitus non clinical, involving persons monocentric A Prof. Dr. rer. nat. Martin Meyer Universität Zürich Universität Zürich, Zürich
Kantonale Ethikkommission Zürich 23.04.2024
2024-00215 CAIN457E22101 - An open-label, multicenter study to evaluate the pharmacokinetics, safety and tolerability of intravenous secukinumab infusion in adults with giant cell arteritis (GCA) or polymyalgia More ... clinical trial drugs phase 1 multicentric C Prof. Dr. med. Thomas Daikeler Novartis Pharma Schweiz AG Universitätsspital Basel, Basel
Inselspital Bern - Universitätsspital, Bern
Kantonsspital St. Gallen, St. Gallen
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern 04.04.2024
2024-00214 DAREON-8: A Phase I, open-label, dose escalation and expansion trial of repeated intravenous infusions of BI 764532 combined with standard of care (platinum, etoposide, and anti-PDL1) in patients with More ... clinical trial drugs phase 1 monocentric C Dr. Hasna Bouchaab Boehringer Ingelheim International GmbH Centre Hospitalier Universitaire Vaudois, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 14.08.2024
2024-00213 A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION clinical trial drugs phase 3 multicentric C Jeroen Goede Pfizer GmbH Kantonsspital Winterthur, Winterthur
Inselspital Bern, Universitätsklinik für Medizinische Onkologie, Bern
Zentrum für Onkologie/Hämatologie Kantonsspital Baden AG, Baden
Département d'oncologie UNIL- More ...
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 07.05.2024
2024-00212 Testing the effectiveness of the culturally adapted skills training START NOW to reduce mental health problems in adolescent refugees clinical trial other clinical trials monocentric A Dr. phil. Donja Brunner University Psychiatric Clinics Basel University Psychiatric Clinics Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 13.03.2024 yes
2024-00210 Seizure, Cognitive, and Functional Outcomes of Pediatric Epilepsy treated with Ketogenic Diet Therapy personal data/biological material monocentric Prof. Dr. med. Georgia Ramantani, PhD Universitäts-Kinderspital Zürich Universitäts-Kinderspital, Zürich
Kantonale Ethikkommission Zürich 26.03.2024